These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1924139)

  • 1. Steady-state pharmacokinetics and pharmacodynamics of benazeprilat in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats.
    LeRoy S; Berner B
    Pharm Res; 1991 Jul; 8(7):883-7. PubMed ID: 1924139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid reversal of angiotensin I-induced contractions in rat carotid arteries after acute and chronic treatment with the angiotensin-converting enzyme inhibitor, 3-[(5-amino-1-carboxy-1S-pentyl)amino]2,3,4,5-tetrahydro-2-oxo- 3S-1H-1-benzazepena-1-acetic acid (CGS 16617).
    Weiss GB; Sturm B; Levens NR
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1407-13. PubMed ID: 8263802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences.
    Bunkenburg B; Schnell C; Baum HP; Cumin F; Wood JM
    Hypertension; 1991 Sep; 18(3):278-88. PubMed ID: 1889842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of amlodipine and benazeprilat in spontaneously hypertensive rats.
    Bazil MK; Webb RL
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):405-11. PubMed ID: 7681501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting activity assessed in vivo is increased in hereditary hypertensive rats.
    Krieger EM; Yamori Y; Lovenberg WM
    Braz J Med Biol Res; 1992; 25(12):1215-22. PubMed ID: 1341916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
    King JN; Mauron C; Kaiser G
    Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renal insufficiency on the pharmacokinetics and pharmacodynamics of benazepril in cats.
    King JN; Strehlau G; Wernsing J; Brown SA
    J Vet Pharmacol Ther; 2002 Oct; 25(5):371-8. PubMed ID: 12423228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
    Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
    Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin of the Y chromosome influences intrarenal vascular responsiveness to angiotensin I and angiotensin (1-7) in stroke-prone spontaneously hypertensive rats.
    Sampson AK; Andrews KL; Graham D; McBride MW; Head GA; Thomas MC; Chin-Dusting JP; Dominiczak AF; Jennings GL
    Hypertension; 2014 Dec; 64(6):1376-83. PubMed ID: 25201895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats.
    Stegbauer J; Oberhauser V; Vonend O; Rump LC
    Cardiovasc Res; 2004 Feb; 61(2):352-9. PubMed ID: 14736552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the angiotensin-converting-enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, in dog.
    King JN; Maurer M; Morrison CA; Mauron C; Kaiser G
    Xenobiotica; 1997 Aug; 27(8):819-29. PubMed ID: 9293618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E; Hollenberg NK
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
    Januszewicz A; Lapiński M; Styś T; Styś A; Loń S
    Pol J Pharmacol; 1994; 46(3):153-61. PubMed ID: 8000447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.
    Daull P; Benrezzak O; Arsenault D; Pheng LH; Blouin A; Cayer J; Beaudoin M; Belleville K; Sirois P; Nantel F; Jeng AY; Battistini B
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1606-13. PubMed ID: 16364833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats.
    Battistini B; Ayach B; Molez S; Blouin A; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():363S-366S. PubMed ID: 12193123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted renal responses to angiotensin II infusion in lifetime captopril-treated spontaneously hypertensive rats.
    Wu JN; Tsai SY; Hsieh WY
    Chin J Physiol; 2001 Jun; 44(2):59-65. PubMed ID: 11530945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an angiotensin-converting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats.
    Nakata K; Nishimura K; Takada T; Ikuse T; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):305-10. PubMed ID: 2437397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a captopril-sensitive angiotensin converting enzyme in the hindquarter vasculature of SHR and WKY.
    Mueller SM; Cohen ML
    Artery; 1985; 12(6):337-45. PubMed ID: 2996465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.